Five Oceans Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 1876326 SANTA MONICA, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$299,804

-$33,150 QoQ

Shares Held

2,373

-0.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#1,647

of 2,266 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Five Oceans Advisors holds $7,614,351 across 12 Drug Manufacturers - General names. GILD ranks #10 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,208	$1,448,911
2	NVS	Novartis AG	7,908	$1,239,341
3	JNJ	Johnson & Johnson	4,196	$1,065,658
4	ABBV	AbbVie Inc.	3,640	$915,969
5	AZN	Astrazeneca PLC	4,009	$760,186
6	MRK	Merck & Co., Inc.	3,157	$405,674
7	NVO	Novo Nordisk A S	7,396	$354,564
8	AMGN	Amgen Inc	931	$337,133

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$299,804	2,373	-0.7%	Shares	Sole	2026-07-15
2026-03-31	$332,954	2,389	+0.4%	Shares	Sole	2026-04-07
2025-12-31	$291,998	2,379	+0.2%	Shares	Sole	2026-01-16
2025-09-30	$263,625	2,375	-3.6%	Shares	Sole	2025-10-22
2025-06-30	$273,183	2,464	+2.3%	Shares	Sole	2025-07-16
2025-03-31	$269,928	2,409	+2.7%	Shares	Sole	2025-04-18
2024-12-31	$216,607	2,345	-16.1%	Shares	Sole	2025-01-24
2024-09-30	$234,332	2,795	-15.4%	Shares	Sole	2024-10-15
2024-03-31	$241,871	3,302	-0.7%	Shares	Sole	2024-04-16
2023-12-31	$269,277	3,324	-1.0%	Shares	Sole	2024-01-22
2023-09-30	$251,723	3,359	+0.1%	Shares	Sole	2023-10-17
2023-06-30	$258,646	3,356	+2.8%	Shares	Sole	2023-07-14
2023-03-31	$270,814	3,264	+16.4%	Shares	Sole	2023-04-14
2022-12-31	$240,637	2,803	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.